GENE ONLINE|News &
Opinion
Blog

2022-05-23| COVID-19Special

Learning From the COVID-19 Pandemic With Moderna CEO, Stéphane Bancel

by Reed Slater
Share To

Over two years into the COVID-19 pandemic, the world has experienced and learned so much about viruses, epidemic response, vaccine technology, and everything else that comes along with living through a global epidemic. At the Future of Everything Festival, Moderna CEO Stéphane Bancel sits down and recounts some valuable lessons the pharmaceutical giant has learned over this time and highlights some hopeful prospects for the future after the pandemic. 

 

Where COVID May Be Heading

 

Over 6 million people worldwide have died due to COVID-19 since it began in late 2019. However, the dominant variant, Omicron, is less dangerous than its predecessors. Though much more virulent, Omicron shows milder symptoms across the board and, compared to Alpha and Delta, is showing signs it may be the light at the end of the tunnel. 

It's free! Log in now to read

LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top